|
Phase 2
|
NCT03161379 |
Feb 2018 → Feb 2024 |
malignant pancreatic neoplasm |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT03006302 |
Jan 2018 → Aug 2023 |
pancreatic adenocarcinoma |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT03190265 |
Dec 2017 → Aug 2022 |
malignant pancreatic neoplasm |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT02004262 |
Feb 2014 → Jan 2016 |
— |
Aduro Biotech, Inc. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01595321 |
Oct 2012 → Oct 2023 |
malignant pancreatic neoplasm |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01088789 |
Apr 2010 → Jul 2024 overdue |
pancreatic adenocarcinoma |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT00389610 |
Sep 2006 → Oct 2021 |
malignant pancreatic neoplasm |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Completed
|
No outcome recorded
|